Summer Sale Get Elite for just $199.50

00

Days

00

Hours

00

Mins

00

Sec

Claim Now

Rafael Holdings, Inc.

Contributing Author

Recent Articles by Rafael Holdings, Inc.

Jun-11	Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results RFL +19.10% GlobeNewswire
Jun-10	Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo for the Treatment of Niemann-Pick Disease Type C RFL -7.77% GlobeNewswire
Apr-22	Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease" RFL GlobeNewswire
Mar-16	Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results RFL GlobeNewswire
Dec-11	Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results RFL GlobeNewswire
Oct-29	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results RFL GlobeNewswire
Oct-28	Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors RFL GlobeNewswire
Sep-16	Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old RFL +6.77% GlobeNewswire
Aug-27	Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM) RFL GlobeNewswire
Jun-18	Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data RFL -19.07% GlobeNewswire
Jun-11	Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results RFL -27.72% GlobeNewswire
Jun-04	Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering RFL +12.68% GlobeNewswire
May-20	Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo RFL GlobeNewswire
May-05	Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol Cyclo RFL -7.14% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)